Possible involvement of nuclear factor erythroid 2-related factor 2 in the gene expression of Cyp2b10 and Cyp2a5

Redox Biology

Volumn 2, Issue 1, 2014, Pages 284-288

  Ashino, Takashi ^a   Ohkubo Morita, Haruyo ^a   Yamamoto, Masayuki ^b   Yoshida, Takemi ^a   Numazawa, Satoshi ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyp2a5; Cyp2b10; Mouse; Nuclear factor erythroid 2 related factor 2; Phenobarbital; Phorone

Indexed keywords

HEME OXYGENASE 1; MESSENGER RNA; PHORONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR NF E2; CYTOCHROME P450 2A5; NAD(P)H QUINONE OXIDOREDUCTASE 1; OXIDOREDUCTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; CYP2A5 PROTEIN, MOUSE; CYP2B10 PROTEIN, MOUSE; HMOX1 PROTEIN, MOUSE; KETONE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE; NOQ1 PROTEIN, MOUSE; PHENOBARBITAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); STEROID MONOOXYGENASE; UNSPECIFIC MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYP2A5 GENE; CYP2B10 GENE; GENE; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENETIC VARIABILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; ANIMAL EXPERIMENT; ATTENUATION; CHEMICAL STRUCTURE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; LIVER PARENCHYMA; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; LIVER; METABOLISM;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; KETONES; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; PHENOBARBITAL; SIGNAL TRANSDUCTION; STEROID HYDROXYLASES;

EID: 84893385046     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.12.025     Document Type: Article

References (24)

1. Gonzalez F.J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 1988, 40:243-288.
2. Isin E.M., Guengerich F.P. Complex reactions catalyzed by cytochrome P450 enzymes. Biochim. Biophys. Acta 2007, 1770:314-329.
3. Rushmore T.H., Kong A.N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 2002, 3:481-490.
4. Abu-Bakar A., Lamsa V., Arpiainen S., Moore M.R., Lang M.A., Hakkola J. Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2. Drug Metab. Dispos. 2007, 35:787-794.
5. Itoh K., Tong K.I., Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 2004, 36:1208-1213.
6. Oguro T., Hayashi M., Numazawa S., Asakawa K., Yoshida T. Heme oxygenase-1 gene expression by a glutathione depletor, phorone, mediated through AP-1 activation in rats. Biochem. Biophys. Res. Commun. 1996, 221:259-265.
7. Kansanen E., Kivela A.M., Levonen A.L. Regulation of Nrf2-dependent gene expression by 15-deoxy-delta12,14-prostaglandin J2. Free Radic. Biol. Med. 2009, 47:1310-1317.
8. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 1991, 266:11632-11639.
9. Alam J., Camhi S., Choi A.M. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J. Biol. Chem. 1995, 270:11977-11984.
10. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
11. Shindo S., Numazawa S., Yoshida T. A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction. Biochem. J. 2007, 401:735-741.
12. Nioi P., McMahon M., Itoh K., Yamamoto M., Hayes J.D. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J. 2003, 374:337-348.
13. Numazawa S., Ishikawa M., Yoshida A., Tanaka S., Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol. 2003, 285:C334-342.
14. Kensler T.W., Egner P.A., Trush M.A., Bueding E., Groopman J.D. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis 1985, 6:759-763.
15. Aleksunes L.M., Slitt A.L., Maher J.M., Augustine L.M., Goedken M.J., Chan J.Y., Cherrington N.J., Klaassen C.D., Manautou J.E. Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol. Appl. Pharmacol. 2008, 226:74-83.
16. Oguro T., Hayashi M., Nakajo S., Numazawa S., Yoshida T. The expression of heme oxygenase-1 gene responded to oxidative stress produced by phorone, a glutathione depletor, in the rat liver; the relevance to activation of c-jun n-terminal kinase. J. Pharmacol. Exp. Ther. 1998, 287:773-778.
17. Honkakoski P., Zelko I., Sueyoshi T., Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell Biol. 1998, 18:5652-5658.
18. Tzameli I., Pissios P., Schuetz E.G., Moore D.D. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol. Cell Biol. 2000, 20:2951-2958.
19. Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell Biol. 1999, 19:6318-6322.
20. Moore L.B., Parks D.J., Jones S.A., Bledsoe R.K., Consler T.G., Stimmel J.B., Goodwin B., Liddle C., Blanchard S.G., Willson T.M., Collins J.L., Kliewer S.A. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 2000, 275:15122-15127.
21. Slitt A.L., Cherrington N.J., Dieter M.Z., Aleksunes L.M., Scheffer G.L., Huang W., Moore D.D., Klaassen C.D. trans-Stilbene oxide induces expression of genes involved in metabolism and transport in mouse liver via CAR and Nrf2 transcription factors. Mol. Pharmacol. 2006, 69:1554-1563.
22. Merrell M.D., Jackson J.P., Augustine L.M., Fisher C.D., Slitt A.L., Maher J.M., Huang W., Moore D.D., Zhang Y., Klaassen C.D., Cherrington N.J. The Nrf2 activator oltipraz also activates the constitutive androstane receptor. Drug Metab. Dispos. 2008, 36:1716-1721.
23. Cui Y., Wang Q., Li X., Zhang X. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation. Redox Biol. 2013, 1:433-440.
24. Xu C., Li C.Y., Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 2005, 28:249-268.